Conduit Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)29holders +11
13new positions
3sold out
1famous investor
$1.07avg. 13F price*
At the end of Q2 2024, 29 institutions reported holding Conduit Pharmaceuticals Inc. in their 13F filings, up 11 from Q1 2024. 13 opened new positions and 3 sold out. The largest holders were Barclays PLC ($861K), BlackRock Inc. ($730K) and Geode Capital Management, LLC ($434K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Conduit Pharmaceuticals Inc.
- CUSIP
- 20678X106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $361K |
| Exits | 3 | $221K |
All 13F filers, Q1 2024 → Q2 2024: 1,429,938 shares bought and 128,161 shares sold, net +1,301,777 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Barclays PLC | 0.00% | Add +1.0% | 812,205 | $861K |
| BlackRock Inc. | 0.00% | Add +301.4% | 688,811 | $730K |
| Geode Capital Management, LLC | 0.00% | Add +194.7% | 409,432 | $434K |
| Vanguard Group Inc. | 0.00% | Add +64.2% | 341,431 | $362K |
| New York State Common Retirement Fund | 0.00% | New | 98,100 | $104K |
| State Street Corp. | 0.00% | Add +454.6% | 84,849 | $90K |
| Marshall Wace, LLP | 0.00% | Reduce -3.6% | 59,728 | $63K |
| Morgan Stanley | 0.00% | Add +381.3% | 56,731 | $60K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 53,111 | $56K |
| Invesco Ltd. | 0.00% | New | 48,143 | $51K |
| Bridgeway Capital Management, LLC | 0.00% | New | 45,000 | $48K |
| Northern Trust Corp. | 0.00% | Add +36.8% | 29,807 | $32K |
| Bank of Montreal | 0.00% | No change | 10,000 | $28K |
| Renaissance Technologies | 0.00% | New | 26,000 | $28K |
| Rhumbline Advisers | 0.00% | New | 23,899 | $25K |
| Alpine Global Management, LLC | 0.00% | New | 21,592 | $23K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -70.7% | 20,075 | $21K |
| UBS Group AG | 0.00% | Add +42136.6% | 17,317 | $18K |
| Corebridge Financial, Inc. | 0.00% | — | 12,399 | $13K |
| Virtu Financial LLC | 0.00% | New | 12,629 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +216.0% | 12,204 | $13K |
| Bank of America Corp. | 0.00% | Add +43.3% | 11,469 | $12K |
| JPMorgan Chase & Co. | 0.00% | Reduce -63.4% | 9,822 | $10K |
| Wells Fargo & Company | 0.00% | Add +11181.3% | 8,461 | $9K |
| Citigroup Inc. | 0.00% | New | 5,411 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 2,258 | $2K |
| Royal Bank of Canada | 0.00% | New | 2,168 | $2K |
| California State Teachers Retirement System | 0.00% | New | 1,670 | $2K |
| Amalgamated Bank | 0.00% | New | 797 | $1K |
"% of holder's portfolio" is CONDUIT PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Conduit Pharmaceuticals Inc. the manager owns.